Rev-dependent Nuclear Export of RNA

RNA 的 Rev 依赖性核输出

• 批准号: 7756518
• 负责人: Mirko Hennig
• 金额: $ 20.28万
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-08-11 至 2011-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7756518
• 关键词: Accounting; Acquired Immunodeficiency Syndrome; Address; Behavior; Binding; Biochemical; Biological Assay; Calorimetry; Cell Nucleus; Chemicals; Chromosomes; Complex; Cytoplasm; Development; Diffusion; Disease; Drug Design; Gel; Gene Expression; Goals; HIV; HIV-1; Immune response; Immune system; Infection; Introns; Length; Link; Maintenance; Measurement; Mediating; Messenger RNA; Modeling; Molecular; Mutation; Nuclear Export; Pathway interactions; Physiologic pulse; Proteins; Proteolysis; RNA; RNA Binding; RNA Splicing; RNA Transport; RNA-Binding Proteins; Research; Resolution; Response Elements; Retroviridae; Role; Running; Sampling; Solutions; Solvents; Spectrum Analysis; Staging; Structural Models; Structure; Structure-Activity Relationship; Testing; Titrations; Transcript; Trifluoroethanol; Variant; Viral; Viral Genes; Viral Proteins; Virion; Virus; Work; antiretroviral therapy; base; cofactor; crosslink; exportin 1 protein; genetic regulatory protein; in vivo; light scattering; mutant; novel; nucleocytoplasmic transport; numb protein; protein structure; public health relevance; receptor; research study; rev Protein; stem; viral RNA

DESCRIPTION (provided by applicant): The Rev-RRE interaction and the subsequent transport of intron-containing viral mRNA mediated by the cellular export receptor CRM1 are essential to the replication of the HIV-1 retrovirus. The current model for oligomeric Rev binding to its cognate RRE is inadequate to fully explain the function of the regulatory protein Rev. While the importance of Rev oligomerization has been previously established, there is no clear molecular basis for understanding the requirements for nuclear transport and the interactions with the nuclear export factor CRM1. We propose to address several mechanistic and structural questions aiming to bridge the gap between Rev-oligomerization, RRE-binding and CRM1-mediated RNA export. Our integrated biochemical, biophysical, and NMR structural studies are centered on the molecular mechanisms by which the regulatory HIV-1 protein Rev attains its biologically active structures. A comprehensive model of how Rev works could potentially facilitate rational drug design targeting this essential viral gene. Our central hypothesis is that Rev function requires: 1) a defined structure and 2) oligomerization ability to serve as a substrate for the cellular export machinery. Monomeric Rev is intrinsically disordered. An on-pathway, partially folded Rev intermediate and the ordered oligomerization nucleus interconvert; a well-ordered Rev structure requires stabilization by either oligomeric binding to RRE, binding to other cofactors, or fibrillation. The proposed development of a comprehensive structure-activity relationship will also test the hypothesis whether modulation of Rev activity could confer positive selection advantages under either host immune responses or antiretroviral therapy that in turn can be linked to the slow progression of AIDS and escape from the immune system. The fundamental question concerning the export activity of the HIV-1 regulatory protein Rev becomes: What are the molecular and mechanistic features connecting Rev structure, Rev oligomerization, oligomeric Rev-RRE assembly and the interaction with cellular CRM1 and Ran-GTP? We propose to answer this question by pursuing the following Specific Aims: 1) Understand the function and molecular mechanism of Rev oligomerization. 2) Elucidate the structures and dynamics of monomeric and oligomeric Rev and of its stem II RRE substrate. 3) Develop mechanistic and structural models for CRM1/Ran-GTP-mediated nuclear export involving oligomeric Rev-RRE substrate complexes. PUBLIC HEALTH RELEVANCE: The HIV retrovirus encodes a small number of proteins and thus must exploit specific cellular cofactors for successful replication. We will investigate the interactions between the essential HIV regulatory protein Rev and cellular proteins involved in nuclear export of viral RNA. Understanding the molecular details of Rev-dependent RNA transport will provide new avenues to therapies that aim at viral eradication.

描述（由申请方提供）：Rev-RRE相互作用和随后由细胞输出受体CRM 1介导的含内含子病毒mRNA的转运对于HIV-1逆转录病毒的复制至关重要。目前的模型寡聚Rev结合到其同源RRE是不足以充分解释的功能的调节蛋白Rev。虽然Rev寡聚化的重要性已经建立以前，没有明确的分子基础，了解核运输的要求和与核输出因子CRM 1的相互作用。我们建议解决几个机制和结构问题，旨在弥合Rev寡聚化，RRE结合和CRM 1介导的RNA输出之间的差距。我们的综合生化，生物物理和NMR结构研究集中在调节HIV-1蛋白Rev获得其生物活性结构的分子机制上。Rev如何工作的综合模型可能有助于针对这种重要病毒基因的合理药物设计。我们的中心假设是Rev功能需要：1）确定的结构和2）寡聚化能力，以作为细胞输出机制的底物。单体Rev本质上是无序的。通路上部分折叠的Rev中间体和有序的寡聚化核相互转化;有序的Rev结构需要通过与RRE的寡聚结合、与其他辅因子的结合或原纤化来稳定。拟议的全面的结构-活性关系的发展也将测试的假设，无论是宿主免疫反应或抗逆转录病毒治疗，反过来可以连接到艾滋病的缓慢进展和逃避免疫系统的Rev活性的调制是否可以赋予积极的选择优势。关于HIV-1调节蛋白Rev的输出活性的基本问题变成：连接Rev结构、Rev寡聚化、寡聚Rev-RRE组装以及与细胞CRM 1和Ran-GTP的相互作用的分子和机制特征是什么？我们提出通过追求以下具体目标来回答这个问题：1）了解Rev寡聚化的功能和分子机制。2)阐明单体和寡聚Rev及其茎II RRE底物的结构和动力学。3)开发CRM 1/Ran-GTP介导的涉及寡聚Rev-RRE底物复合物的核输出的机制和结构模型。公共卫生相关性：HIV逆转录病毒编码少量蛋白质，因此必须利用特定的细胞辅因子进行成功复制。我们将研究HIV关键调节蛋白Rev和参与病毒RNA核输出的细胞蛋白之间的相互作用。了解Rev依赖性RNA转运的分子细节将为旨在根除病毒的治疗提供新的途径。